drugset / Trial / NCT04871204
Octreotide Treatment to Improve Nutritional Recovery After Surgery for Patients with Esophageal or Gastric Cancer
Phase 2
Completed
20 enrolled
Karolinska University Hospital
Karolinska University Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of the study is to clarify whether octreotide therapy can reduce undesired postoperative weight loss, increase health-related quality of life and improve the appetite after surgery for esophageal or gastric cancer.
Timeline
- Start
- 2021-06-16
- Primary completion
- 2024-02-21
- Completion
- 2024-02-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Octreotide | Peptide | 10 mg | Intramuscular |